The Food and Drug Administration seems resolute to start a new attempt to curb nicotine addiction. The agency announced that it is definitely going to take some steps against the tobacco industry and its popularity of harmful cigarettes. One of the major changes will be decreasing the levels of nicotine in products until they reach a non-addictive point which might be a solution to preventable death.
In the Past, FDA Was Busy Applying More Steep Regulations to e-Cigarette Companies than to Big Tobacco
After the FDA announcement of reducing nicotine levels in cigarettes, tobacco companies witnessed their stocks plummeting to record lows. The agency surprised executives as they were expecting the Trump administration to encourage a milder approach to regulation than before.
However, the news might work miracles for a contiguous market, namely the business of vapor products and e-cigarettes. Even though the agency needs the input of vast scientific findings to implement the right regulations, the public health has just won a great ally as FDA embraces smoking alternatives.
The FDA has only eight years since it gained the authority to control this industry through regulations thanks to President Barack Obama. However, it did little with its new influence. The area where it truly excelled was the protection of the Big Tobacco even though it continues to be the leading cause of preventable death. Therefore, the competition that consists mostly of healthier choices such as e-cigarettes was the only one to suffer.
The New FDA Chief Was the First to Mention Cigarettes as Causes of Preventable Death
Consequently, the news from last Friday came as a surprise to all. The new FDA Commissioner Scott Gottlieb was the first authority in eight years who openly addressed the concerning negative side effects of a population’s addiction to nicotine.
So far, the agency imposed strict rules for e-cigarette players. They have to reapply for their pre-market approval. However, the protocols consist of vague mazes that only the big tobacco companies have the knowledge and resources to get through with them. Consequently, industry’s behemoths invested heavily in alternative smoking methods which presented a serious hit to small players.
Nonetheless, the agency extended the deadline for applications to 2022. This constitutes enough time for FDA to investigate the real influence e-cigarettes have on breaking the smoking habit. In the end, authorities might create general standards that will help companies to have a cheaper and more effective research on products than before.
Image source: 1